Tylenol is owned by Kenvue, a company that was spun off from Johnson & Johnson in 2023. Kenvue is an American consumer health company headquartered in Summit, New Jersey, and it owns several well-known brands including Tylenol. The Tylenol brand itself was originally introduced in 1955 by McNeil Laboratories, which was acquired by Johnson & Johnson in 1959. In 2023, the consumer health division, including Tylenol, was separated into the new entity Kenvue.
